Skip to main content
Erschienen in: International Journal of Clinical Oncology 2/2010

01.04.2010 | Special Article

Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition

verfasst von: Satoru Nagase, Yoshiki Inoue, Naohiko Umesaki, Daisuke Aoki, Masatsugu Ueda, Hideki Sakamoto, Shigemitsu Kobayashi, Ryo Kitagawa, Takafumi Toita, Shoji Nagao, Kiyoshi Hasegawa, Ichio Fukasawa, Keiichi Fujiwara, Yoh Watanabe, Kiyoshi Ito, Hitoshi Niikura, Tsuyoshi Iwasaka, Kazunori Ochiai, Hidetaka Katabuchi, Toshiharu Kamura, Ikuo Konishi, Noriaki Sakuragi, Tadao Tanaka, Yasuo Hirai, Yuji Hiramatsu, Makio Mukai, Hiroyuki Yoshikawa, Tadao Takano, Kosuke Yoshinaga, Takeo Otsuki, Michiko Sakuma, Noriyuki Inaba, Yasuhiro Udagawa, Nobuo Yaegashi

Erschienen in: International Journal of Clinical Oncology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Clinical practice guidelines for gynecologic cancers have been published by the National Comprehensive Cancer Network and the National Cancer Institute. Whereas these guidelines form the basis for the standard of care for gynecologic malignancies in the United States, it has proven difficult to institute them in Japan due to differences in patient characteristics, health-care delivery systems, and insurance programs. Therefore, evidence-based guidelines for treating cervical cancer specifically in Japan have been under development. The Guidelines Formulation Committee and Evaluation Committee were independently established within the Committee for Treatment Guidelines for Cervical Cancer. Opinions from within and outside the Japan Society of Gynecologic Oncology (JSGO) were incorporated into the final draft, and the guidelines were published after approval by the JSGO. These guidelines are composed of ten chapters and comprise three algorithms. Each chapter consists of a clinical question, recommendations, background, objectives, explanations, and references. The objective of these guidelines is to clearly delineate the standard of care for cervical cancer treatment in Japan in order to ensure equitable care for all Japanese women diagnosed with cervical cancer.
Literatur
1.
Zurück zum Zitat Ushijima K (2009) Current status of gynecologic cancer in Japan. J Gynecol Oncol 20(2):67–71CrossRefPubMed Ushijima K (2009) Current status of gynecologic cancer in Japan. J Gynecol Oncol 20(2):67–71CrossRefPubMed
2.
Zurück zum Zitat Pearcey R, Miao Q, Kong W et al (2007) Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: results of a population based cohort study. J Clin Oncol 25:2383–2388CrossRefPubMed Pearcey R, Miao Q, Kong W et al (2007) Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: results of a population based cohort study. J Clin Oncol 25:2383–2388CrossRefPubMed
Metadaten
Titel
Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition
verfasst von
Satoru Nagase
Yoshiki Inoue
Naohiko Umesaki
Daisuke Aoki
Masatsugu Ueda
Hideki Sakamoto
Shigemitsu Kobayashi
Ryo Kitagawa
Takafumi Toita
Shoji Nagao
Kiyoshi Hasegawa
Ichio Fukasawa
Keiichi Fujiwara
Yoh Watanabe
Kiyoshi Ito
Hitoshi Niikura
Tsuyoshi Iwasaka
Kazunori Ochiai
Hidetaka Katabuchi
Toshiharu Kamura
Ikuo Konishi
Noriaki Sakuragi
Tadao Tanaka
Yasuo Hirai
Yuji Hiramatsu
Makio Mukai
Hiroyuki Yoshikawa
Tadao Takano
Kosuke Yoshinaga
Takeo Otsuki
Michiko Sakuma
Noriyuki Inaba
Yasuhiro Udagawa
Nobuo Yaegashi
Publikationsdatum
01.04.2010
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 2/2010
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-010-0061-x

Weitere Artikel der Ausgabe 2/2010

International Journal of Clinical Oncology 2/2010 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.